Symbols / SNYR $0.74 -7.98% Synergy CHC Corp.

Healthcare • Medical Distribution • United States • NCM
SNYR Chart
About

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; beauty products for the eyes, lips, brows, cheeks, and skin under the Perfekt Beauty brand; shapewear, bralettes, and panties under Sneaky Vaunt brand; eyelash enhancement products under The Queen Pegasus brand; topical treatments for neuropathic pain under Neuragen brand; and over-the-counter medications under UrgentRx brand. It sells its products through club, mass drug, and other retailers. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. The company was incorporated in 2010 and is based in Westbrook, Maine.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Distribution Market Cap 8.28M
Enterprise Value 33.24M Income -12.34M Sales 30.38M
Book/sh -0.73 Cash/sh 0.23 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E 4.21 Forward P/E 1.24 PEG —
P/S 0.27 P/B -1.00 P/C —
EV/EBITDA -3.99 EV/Sales 1.09 Quick Ratio 0.71
Current Ratio 1.22 Debt/Eq — LT Debt/Eq —
EPS (ttm) -1.27 EPS next Y 0.59 EPS Growth —
Revenue Growth -41.00% Earnings 2026-05-15 ROA -39.89%
ROE — ROIC — Gross Margin 66.83%
Oper. Margin -219.45% Profit Margin -40.62% Shs Outstand 11.25M
Shs Float 4.89M Short Float 1.13% Short Ratio 2.00
Short Interest — 52W High 4.08 52W Low 0.71
Beta — Avg Volume 30.41K Volume 27.28K
Target Price $6.00 Recom None Prev Close $0.80
Price $0.74 Change -7.98%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.00
Mean price target
2. Current target
$0.74
Latest analyst target
3. DCF / Fair value
$2.85
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.74
Low
$5.00
High
$7.00
Mean
$6.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-02 init Ascendiant Capital — → Buy $5
2025-11-14 main Roth Capital Buy → Buy $7
2025-01-21 init Roth MKM — → Buy $10
News
RSS: Latest SNYR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-07-30 ROSS JACK Chief Executive Officer — 27,900 $2.15 $79,578
2025-06-10 ROSS JACK Chief Executive Officer — 16,100 $1.74 $29,837
2025-05-15 ROSS JACK Chief Executive Officer — 5,300 $1.83 $10,870
2025-04-10 ROSS JACK Chief Executive Officer — 14,040 $1.78 $38,150
2025-02-21 ROSS JACK Chief Executive Officer — 15,200 $3.41 $59,521
2025-01-22 ROSS JACK Chief Executive Officer — 5,170 $4.06 $25,460
2024-10-24 ROSS JACK Chief Executive Officer — 300,000 $9.00 $2,700,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Revenue
30.38
-12.78%
34.83
-18.57%
42.78
Operating Revenue
30.38
-12.78%
34.83
-18.57%
42.78
Cost Of Revenue
10.08
-9.95%
11.19
+4.62%
10.70
Reconciled Cost Of Revenue
10.08
-9.95%
11.19
+4.62%
10.70
Gross Profit
20.30
-14.13%
23.64
-26.30%
32.08
Operating Expense
22.10
+23.87%
17.84
-16.13%
21.27
Selling General And Administration
21.97
+24.05%
17.71
-16.63%
21.24
Selling And Marketing Expense
13.14
+1.13%
12.99
-14.47%
15.19
General And Administrative Expense
8.83
+87.19%
4.72
-22.05%
6.05
Other Gand A
8.83
+87.19%
4.72
-22.05%
6.05
Total Expenses
32.18
+10.84%
29.03
-9.19%
31.97
Operating Income
-1.80
-131.00%
5.80
-46.32%
10.81
Total Operating Income As Reported
-8.46
-245.81%
5.80
-46.32%
10.81
EBITDA
-6.17
-195.44%
6.47
-40.37%
10.84
Normalized EBITDA
0.49
-92.42%
6.47
-40.37%
10.84
Reconciled Depreciation
0.13
+0.00%
0.13
+300.01%
0.03
EBIT
-6.30
-199.55%
6.33
-41.42%
10.81
Total Unusual Items
-6.66
0.00
-100.00%
0.00
Total Unusual Items Excluding Goodwill
-6.66
0.00
-100.00%
0.00
Special Income Charges
-6.66
0.00
—
Write Off
6.66
0.00
—
Net Income
-12.34
-680.77%
2.12
-66.48%
6.34
Pretax Income
-12.22
-648.87%
2.23
-66.12%
6.57
Net Non Operating Interest Income Expense
-5.90
-43.89%
-4.10
+3.09%
-4.23
Interest Expense Non Operating
5.92
+44.20%
4.11
-3.09%
4.24
Net Interest Income
-5.90
-43.89%
-4.10
+3.09%
-4.23
Interest Expense
5.92
+44.20%
4.11
-3.09%
4.24
Interest Income Non Operating
0.02
+889.17%
0.00
-5.75%
0.00
Interest Income
0.02
+889.17%
0.00
-5.75%
0.00
Other Income Expense
-4.52
-953.84%
0.53
+34803.63%
0.00
Other Non Operating Income Expenses
2.14
+304.11%
0.53
+34803.63%
0.00
Gain On Sale Of Security
—
0.02
+1149.44%
0.00
Tax Provision
0.12
+15.07%
0.10
-56.56%
0.23
Tax Rate For Calcs
0.00
+425.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-1.40
0.00
0.00
Net Income Including Noncontrolling Interests
-12.34
-680.77%
2.12
-66.48%
6.34
Net Income From Continuing Operation Net Minority Interest
-12.34
-680.77%
2.12
-66.48%
6.34
Net Income From Continuing And Discontinued Operation
-12.34
-680.77%
2.12
-66.48%
6.34
Net Income Continuous Operations
-12.34
-680.77%
2.12
-66.48%
6.34
Normalized Income
-7.08
-433.15%
2.12
-66.48%
6.34
Net Income Common Stockholders
-12.34
-680.77%
2.12
-66.48%
6.34
Diluted EPS
—
0.28
-67.44%
0.86
Basic EPS
—
0.28
-67.44%
0.86
Basic Average Shares
—
7.59
+2.91%
7.37
Diluted Average Shares
—
7.63
+3.48%
7.37
Diluted NI Availto Com Stockholders
-12.34
-680.77%
2.12
-66.48%
6.34
Depreciation Amortization Depletion Income Statement
0.13
+0.00%
0.13
+300.01%
0.03
Depreciation And Amortization In Income Statement
0.13
+0.00%
0.13
+300.01%
0.03
Line Item Trend 2024-12-31
Total Assets
16.34
Current Assets
16.06
Cash Cash Equivalents And Short Term Investments
0.69
Cash And Cash Equivalents
0.69
Cash Financial
0.69
Receivables
11.70
Accounts Receivable
5.32
Gross Accounts Receivable
5.32
Allowance For Doubtful Accounts Receivable
0.00
Other Receivables
2.00
Loans Receivable
4.38
Inventory
1.72
Raw Materials
0.14
Finished Goods
1.58
Prepaid Assets
1.86
Restricted Cash
0.10
Total Non Current Assets
0.28
Goodwill And Other Intangible Assets
0.28
Other Intangible Assets
0.28
Total Liabilities Net Minority Interest
32.97
Current Liabilities
17.18
Payables And Accrued Expenses
5.43
Payables
1.01
Current Accrued Expenses
4.42
Total Tax Payable
1.01
Income Tax Payable
0.24
Current Debt And Capital Lease Obligation
11.73
Current Debt
11.73
Other Current Borrowings
11.73
Current Deferred Liabilities
0.02
Current Deferred Revenue
0.02
Other Current Liabilities
—
Total Non Current Liabilities Net Minority Interest
15.79
Long Term Debt And Capital Lease Obligation
15.79
Long Term Debt
15.79
Stockholders Equity
-16.63
Common Stock Equity
-16.63
Capital Stock
0.00
Common Stock
0.00
Share Issued
8.72
Ordinary Shares Number
8.54
Treasury Shares Number
0.18
Additional Paid In Capital
27.64
Retained Earnings
-44.10
Gains Losses Not Affecting Retained Earnings
-0.05
Treasury Stock
0.13
Other Equity Adjustments
-0.05
Total Equity Gross Minority Interest
-16.63
Total Capitalization
-0.84
Working Capital
-1.12
Invested Capital
10.88
Total Debt
27.52
Net Debt
26.83
Net Tangible Assets
-16.91
Tangible Book Value
-16.91
Interest Payable
0.00
Other Inventories
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Operating Cash Flow
-2.59
+46.18%
-4.80
-1238.98%
0.42
Cash Flow From Continuing Operating Activities
-2.59
+46.18%
-4.80
-1238.98%
0.42
Net Income From Continuing Operations
-12.34
-680.77%
2.12
-66.48%
6.34
Depreciation Amortization Depletion
0.13
+0.00%
0.13
+300.01%
0.03
Amortization Cash Flow
0.13
+0.00%
0.13
+300.01%
0.03
Depreciation And Amortization
0.13
+0.00%
0.13
+300.01%
0.03
Amortization Of Intangibles
0.13
+0.00%
0.13
+300.01%
0.03
Other Non Cash Items
4.02
+4174.29%
-0.10
+97.80%
-4.47
Pension And Employee Benefit Expense
0.00
+100.00%
-0.25
0.00
Stock Based Compensation
0.98
0.00
—
Asset Impairment Charge
5.30
+4126.21%
0.13
-50.06%
0.25
Operating Gains Losses
-2.13
-883.31%
-0.22
-103.39%
-0.11
Net Foreign Currency Exchange Gain Loss
0.02
-42.42%
0.04
+133.14%
-0.11
Change In Working Capital
1.46
+121.21%
-6.87
-324.18%
-1.62
Change In Receivables
1.86
+140.27%
-4.62
-444.27%
1.34
Changes In Account Receivables
1.51
+147.12%
-3.21
-333.20%
1.38
Change In Inventory
-2.92
-254.71%
1.88
-52.78%
3.99
Change In Prepaid Assets
1.51
+208.13%
-1.40
-111.95%
-0.66
Change In Payables And Accrued Expense
1.03
+137.32%
-2.75
+56.34%
-6.30
Change In Payable
1.03
+137.32%
-2.75
+56.34%
-6.30
Change In Account Payable
1.11
+139.56%
-2.81
+56.71%
-6.49
Change In Other Working Capital
-0.02
-326.13%
0.01
+11.60%
0.01
Investing Cash Flow
0.00
0.00
0.00
Financing Cash Flow
4.65
-3.11%
4.80
+329.77%
-2.09
Cash Flow From Continuing Financing Activities
4.65
-3.11%
4.80
+329.77%
-2.09
Net Issuance Payments Of Debt
2.86
+172.93%
-3.92
-87.54%
-2.09
Issuance Of Debt
21.00
+1443.84%
1.36
+277.78%
0.36
Repayment Of Debt
-18.14
-243.44%
-5.28
-115.48%
-2.45
Long Term Debt Issuance
21.00
+1443.84%
1.36
+277.78%
0.36
Long Term Debt Payments
-18.14
-243.44%
-5.28
-115.48%
-2.45
Net Long Term Debt Issuance
2.86
+172.93%
-3.92
-87.54%
-2.09
Net Common Stock Issuance
3.72
-55.70%
8.40
0.00
Net Other Financing Charges
-1.92
-686.67%
0.33
—
Changes In Cash
2.07
+297262.36%
0.00
+100.04%
-1.67
Effect Of Exchange Rate Changes
-0.14
-347.30%
0.05
+143.80%
-0.12
Beginning Cash Position
0.79
+7.56%
0.73
-71.01%
2.53
End Cash Position
2.72
+245.51%
0.79
+7.56%
0.73
Free Cash Flow
-2.59
+46.18%
-4.80
-1238.98%
0.42
Interest Paid Supplemental Data
2.95
-24.38%
3.91
-6.44%
4.17
Income Tax Paid Supplemental Data
0.15
0.00
0.00
Change In Income Tax Payable
-0.08
-247.04%
0.06
-69.13%
0.19
Change In Tax Payable
-0.08
-247.04%
0.06
-69.13%
0.19
Common Stock Issuance
3.72
-55.70%
8.40
0.00
Issuance Of Capital Stock
3.72
-55.70%
8.40
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category